Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Clark

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Journal of Aerosol Medicine and Pulmonary Drug Delivery|October 16, 2019
The Confusing World of Dry Powder Inhalers: It Is All About Inspiratory Pressures, Not Inspiratory Flow RatesAndrew R Clark, Jeffry G Weers, Rajiv Dhand
Expert Opinion on Drug Delivery|May 11, 2007
Design of fine particles for pulmonary drug deliveryJeffry G Weers, Thomas E Tarara, Andrew R Clark
FEBS Letters|June 28, 2003
Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38Andrew R Clark, Jonathan L E Dean, Jeremy Saklatvala
Arthritis and Rheumatism|October 31, 2009
The p38 MAPK pathway mediates both antiinflammatory and proinflammatory processes: comment on the article by Damjanov and the editorial by GenoveseAndrew R Clark, Jonathan L E Dean, Jeremy Saklatvala
The Journal of Biological Chemistry|June 11, 2008
Role of dual specificity phosphatases in biological responses to glucocorticoidsAndrew R Clark, Joana R S Martins, Carmen R Tchen
Blood|September 4, 2004
Stabilization of IFN-gamma mRNA by MAPK p38 in IL-12- and IL-18-stimulated human NK cellsAthanasios Mavropoulos, Gareth Sully, Andrew P Cope, et al.
The Journal of Biological Chemistry|June 10, 2004
The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itselfCarmen R Tchen, Matthew Brook, Jeremy Saklatvala, et al.
Arthritis and Rheumatism|February 24, 2010
Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugsRiina Nieminen, Riku Korhonen, Teemu Moilanen, et al.
Frontiers in Immunology|May 17, 2021
Mitochondria as Key Players in the Pathogenesis and Treatment of Rheumatoid ArthritisSally A Clayton, Lucy MacDonald, Mariola Kurowska-Stolarska, et al.
Cellular Signalling|July 9, 2004
The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisationJonathan L E Dean, Gareth Sully, Andrew R Clark, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Journal of Aerosol Medicine and Pulmonary Drug Delivery|October 16, 2019
The Confusing World of Dry Powder Inhalers: It Is All About Inspiratory Pressures, Not Inspiratory Flow RatesAndrew R Clark, Jeffry G Weers, Rajiv Dhand
Expert Opinion on Drug Delivery|May 11, 2007
Design of fine particles for pulmonary drug deliveryJeffry G Weers, Thomas E Tarara, Andrew R Clark
FEBS Letters|June 28, 2003
Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38Andrew R Clark, Jonathan L E Dean, Jeremy Saklatvala
Arthritis and Rheumatism|October 31, 2009
The p38 MAPK pathway mediates both antiinflammatory and proinflammatory processes: comment on the article by Damjanov and the editorial by GenoveseAndrew R Clark, Jonathan L E Dean, Jeremy Saklatvala
The Journal of Biological Chemistry|June 11, 2008
Role of dual specificity phosphatases in biological responses to glucocorticoidsAndrew R Clark, Joana R S Martins, Carmen R Tchen
Blood|September 4, 2004
Stabilization of IFN-gamma mRNA by MAPK p38 in IL-12- and IL-18-stimulated human NK cellsAthanasios Mavropoulos, Gareth Sully, Andrew P Cope, et al.
The Journal of Biological Chemistry|June 10, 2004
The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itselfCarmen R Tchen, Matthew Brook, Jeremy Saklatvala, et al.
Arthritis and Rheumatism|February 24, 2010
Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugsRiina Nieminen, Riku Korhonen, Teemu Moilanen, et al.
Frontiers in Immunology|May 17, 2021
Mitochondria as Key Players in the Pathogenesis and Treatment of Rheumatoid ArthritisSally A Clayton, Lucy MacDonald, Mariola Kurowska-Stolarska, et al.
Cellular Signalling|July 9, 2004
The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisationJonathan L E Dean, Gareth Sully, Andrew R Clark, et al.
Pageof 9